Baird Medical Investment Holdings Ltd (BDMD:NASDAQ)
$3.1 -0.01 (-0.32%)
Analysed Baird Medical Investment Holdings Ltd (BDMD:NASDAQ) News Sources
Baird Medical Accelerates Global Registration of AI-Driven Surgical Software
Yahoo Finance
Baird Medical Accelerates U.S. Expansion at NASOIE 2026
Yahoo Finance UK
Novo Holdings scales up India bets with bigger cheques, focus on mature healthcare assets
Mint
India's medical tech sector set to get 1st dedicated fund of 1,000 crore
The Times of India on MSN
Fortrea Holdings Inc. (FTRE) 2026 Guidance Assumes Stable FX Rates from End-2025
Yahoo Finance
American Securities Announces Agreement to Sell CPM and MW Components
TMCnet
Ranpak Holdings Corp. (PACK) Q4 2025 Earnings Call Transcript
Seeking Alpha
Are PE-backed hospitals driving up healthcare costs in India?
Business Today on MSN
Betadine maker Win-Medicare eyes $150-200 million stake sale; taps EY
Mint
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Block, CrowdStrike, Fortinet, MongoDB, Mosaic, Palo Alto Networks, Unity Software, and More
AOL
What is the current price of Baird Medical Investment Holdings Ltd (BDMD:NASDAQ)?
The current price of Baird Medical Investment Holdings Ltd (BDMD:NASDAQ) is $3.1.
Baird Medical Investment Holdings Ltd (BDMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of Baird Medical Investment Holdings Ltd (BDMD:NASDAQ) since the previous trading day is $-0.01.
Baird Medical Investment Holdings Ltd (BDMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of Baird Medical Investment Holdings Ltd (BDMD:NASDAQ) since the previous trading day is -0.32%.
What is This Week's average sentiment score for Baird Medical Investment Holdings Ltd (BDMD:NASDAQ)?
This Week's average sentiment score for Baird Medical Investment Holdings Ltd (BDMD:NASDAQ) is 67 out of 100.
What is This Week's average sentiment for Baird Medical Investment Holdings Ltd (BDMD:NASDAQ)?
This Week's sentiment for Baird Medical Investment Holdings Ltd (BDMD:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.